Hemophagocytic Lymphohistiocytoses Clinical Trial
Official title:
Retrospective Analysis of the Outcome of Patients Diagnosed With Hemophagocytic Lymphohistiocytosis (HLH) Treated at the S.C.Pediatric Oncohematology of the Regina Margherita Torino Hospital (OIRM)
Monocentric, observational, retrospective, no profit study aimed to analyze factors that are significantly impacting the outcome of patients diagnosed with HLH.
retrospective data collection to study: type of HLH familial vs secondary, sex, age, presence of infectious cause, involvement central nervous system ( SNC), hepatic involvement, presence of hemophagocytosis, presence of splenomegaly, presence of involvement of other organs, the value of neutrophils (PMN), the value of hemoglobin, platelets, albumin, triglycerides, ferritin, LDH, type of therapy and the response to therapy after 2 months ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05491304 -
Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis
|
Phase 4 | |
Not yet recruiting |
NCT05600959 -
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
|
||
Completed |
NCT03546101 -
Early Detection of Epstein-Barr Virus Related Disease.
|
||
Recruiting |
NCT05898477 -
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
|
||
Recruiting |
NCT05882175 -
Prospective Validation of the OHI Index
|
||
Recruiting |
NCT05146336 -
CytOSorb TreatMent Of Critically Ill PatientS Registry
|
||
Not yet recruiting |
NCT04902807 -
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
|
||
Terminated |
NCT03985423 -
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
|
Phase 2/Phase 3 | |
Completed |
NCT03513328 -
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05677178 -
Response Prediction in EBV-HLH Using Metabonomics Analysis
|
||
Recruiting |
NCT03117010 -
Prospective Cohort for Adult Hemophagocytosis
|
||
Not yet recruiting |
NCT06160791 -
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
|
Phase 2 | |
Recruiting |
NCT05236764 -
Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion
|
N/A | |
Recruiting |
NCT05277272 -
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
|
||
Completed |
NCT06047210 -
Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis
|
||
Not yet recruiting |
NCT05988177 -
Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections
|
N/A |